z-logo
open-access-imgOpen Access
Stellera chamaejasme L. extract induces apoptosis of human lung cancer cells via activation of the death receptor-dependent pathway
Author(s) -
Xiaoni Liu,
Xiaoxin Zhu
Publication year - 2012
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2012.643
Subject(s) - apoptosis , cancer research , lung cancer , programmed cell death , cell cycle , medicine , oncogene , cell growth , cell culture , cell , cancer , cancer cell , biology , pathology , biochemistry , genetics
Stellera chamaejasme L. has been widely used in the treatment of lung, liver and esophageal cancer in Chinese traditional medicine. In our previous study, we found that the extract of Stellera chamaejasme L. (ESC) inhibited the growth and induced the apoptosis of human lung cancer NCI-H157 cells. In the present study, we investigated the cellular effects of an ESC-2 extract isolated from ESC in the NCI-H157 human lung cancer cell line. We found that ESC-2 inhibited the growth of NCI-H157 cells, demonstrating ESC-2-induced morphological changes in cells and reduced cell viability in a dose- and time-dependent manner. Furthermore, we observed that ESC-2 resulted in apoptosis, activation of caspase-8 and caspase-3, and an increase in Fas expression, indicating that the NCI-H157 cell growth inhibitory activity of ESC-2 was due to death receptor-dependent pathway-mediated apoptosis, which may partly explain the anti-cancer activity of ESC-2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom